SLAs, MOQs, lead times: a 4×4 silicone foam supply checklist for decision-stage POs

If you’re already at the “ready to place a PO” stage, the failure mode isn’t usually product selection. It’s signing a clean set of commercial terms (MOQs, lead times, OTIF) without the quality/traceability layer that makes those terms enforceable.

This checklist is designed for overseas medical consumables distributors who need a contract-ready way to qualify 4×4 silicone foam supply—including mix-and-match PO structures, sterilization documentation, shelf life controls, traceability, and complaint/CAPA response expectations.

Key Takeaway: A procurement SLA only works if it is measurable, auditable, and tied to the quality records you’ll need when something goes wrong—see IBM’s overview of service level agreements (SLAs) for the baseline definition.

Why “SLA + MOQ + lead time” fails without a quality layer

In medical dressings, delivery performance and quality performance are tightly linked. If you don’t specify what records must exist (and how quickly you get them), your team can’t investigate deviations, manage shelf-life risk, or contain complaints efficiently.

That’s why many buyers pair commercial terms with a supplier quality agreement that defines responsibilities for complaints, CAPA, change notifications, audits, and record retention (see MasterControl’s supplier quality agreement overview (2021) and Greenlight Guru’s medical device quality agreement guide).

Pre-RFQ checklist (spec + documentation + traceability)

Use this section to decide whether a supplier is even eligible for an RFQ.

A. Spec definition (so MOQ and lead time are comparable)

• Your 4×4 configuration is defined (bordered vs non-bordered, thickness, absorbency target, adhesive footprint). Yes/No

• Your packaging format is defined (unit pack, inner/outer cartons, case pack). Yes/No

• Your labeling requirements are defined (language set, symbols, barcode requirements). Yes/No

• Your acceptance criteria are defined (what gets checked at incoming inspection). Yes/No

If you need a structured way to define evaluation metrics (beyond “feels soft”), start with a spec scorecard like SLK Medical’s silicone foam metrics checklist and scorecard.

B. Required document pack (procurement + QA)

• Supplier provides a documented quality system overview and audit approach. Yes/No

• Supplier can provide release documentation with each shipment (e.g., CoC and batch/lot identifiers). Yes/No

• Supplier has a defined complaint handling and CAPA process (ownership + timelines). Yes/No

• Supplier has a defined change notification process (materials, process, site, packaging, labeling). Yes/No

For a deeper compliance checklist you can adapt into your RFQ, see SLK Medical’s procurement compliance checklist for silicone foam suppliers.

C. Traceability reality check (what you’ll need when you get a complaint)

• Lot/batch traceability exists from finished goods back to critical materials and process records. Yes/No

• Label data fields are defined and consistently captured (lot/batch, manufacture/expiry as applicable). Yes/No

• Supplier can demonstrate a “trace forward/trace back” example within an agreed time window. Yes/No

If UDI applies in your market, make sure your supplier can link label identifiers to production information. The U.S. FDA explains core UDI components (and what production identifiers can include) in UDI Basics.

Common regulatory anchors (examples): U.S. 21 CFR 801.20 (UDI on labels) + 21 CFR Part 830 (UDI system), and EU MDR Article 27 + Annex VI (UDI system, incl. Basic UDI-DI and UDI-PI).

PO + planning checklist (MOQs, mix-and-match POs, lead time definition, OTIF)

This is where most “we had an agreement” disputes start—because the terms were never defined precisely.

A. MOQ structure (write it so finance and operations can execute)

• MOQ is defined per SKU (not just “per order”). Yes/No

• MOQ is defined per packaging configuration (e.g., private label vs standard). Yes/No

• MOQ is defined per sterilization status (sterile vs non-sterile), if applicable. Yes/No

• The “what counts toward MOQ” rule is clear. Yes/No

Pro Tip: Add a mix-and-match clause if you need it. Example field: “MOQ may be met by combining ____ SKUs within the same ____ (production window / shipment / sterilization run), subject to agreed packaging constraints.”

B. Mix-and-match PO options (reduce dead stock without breaking production logic)

• Supplier confirms whether mixed-SKU POs are allowed. Yes/No

• Supplier confirms whether mixed-language labeling in one PO is allowed. Yes/No

• Supplier confirms whether mixed-packaging (standard + OEM/private label) is allowed. Yes/No

• Any constraints are explicit (e.g., artwork approval, label changeover time, packaging validation needs). Yes/No

If you are evaluating private label or OEM routes, align early on what can be customized and what must stay standard. For context on OEM supply programs, see OEM silicone foam supply for sacral and heel products.

C. Lead time definition (no more “30 days from when?”)

• Lead time start point is defined: PO release vs order acceptance. Yes/No

• Lead time end point is defined: ship date vs receipt date. Yes/No

• Calendar vs business days is specified. Yes/No

• Cutoff times and holiday rules are specified. Yes/No

• Expedite rules are specified (what changes, what stays the same). Yes/No

You can sanity-check your definition against a plain-language lead time overview such as this ASCM/APICS glossary entry for “lead time”: https://www.ascm.org/ascm-insights/definitions/lead-time/

D. OTIF / fill rate (avoid “partial shipments still count” arguments)

• OTIF is defined at PO-line level (not just whole-order). Yes/No

• “On time” window is defined (including early/late tolerance). Yes/No

• “In full” is defined (unit of measure, substitutions allowed/not allowed). Yes/No

• Split shipments rules are defined (can a line still be OTIF?). Yes/No

• Reporting cadence is defined (monthly/quarterly) with a shared system of record. Yes/No

For plain-language OTIF definitions and typical measurement pitfalls, see MRPeasy’s OTIF guide (2024).

Sterilization, shelf life, and release documentation checklist

If your program includes sterilization (e.g., EO), you want to avoid two common risks: (1) sterile claims without the right traceability, and (2) inventory that arrives too close to expiry to sell through.

A. Sterilization lot linkage (what you need to trace)

Common standards to cite (as applicable): ISO 11135 (ethylene oxide sterilization) and ISO 11137 (radiation sterilization) for validation and routine control of sterilization processes.

• Sterilization status is specified in the PO and labeling. Yes/No

• Each shipment is traceable to a defined lot/batch and associated release documentation. Yes/No

• The document pack required per lot is specified (and who receives it). Yes/No

B. Shelf life controls (define your minimum—don’t inherit the supplier’s convenience)

• Your minimum remaining shelf life at receipt is defined: ________ Yes/No

• The PO states your shelf-life minimum requirement. Yes/No

• FEFO (first-expired, first-out) is enforced in your warehouse. Yes/No

• Receiving SOP includes packaging integrity checks (sterile packaging must be intact and dry). Yes/No

For background on why packaging integrity is central to sterile shelf-life concepts, see the Association for the Advancement of Medical Instrumentation (AAMI) Sterilization FAQs: “How long are items good for once sterilized?”.

Post-award support checklist (complaints, CAPA, and change notifications)

This section is what protects you after you’ve already placed orders and product is in the field.

A. Complaint handling SLA (define time-to-ack and time-to-answer)

• Complaint intake channel and required fields are defined (photos, lot, expiry, description, samples). Yes/No

• Acknowledgement SLA is defined: ________ Yes/No

• Initial investigation update SLA is defined: ________ Yes/No

• Final investigation response SLA is defined: ________ Yes/No

• Escalation path is defined (supply + QA contacts, after-hours rules). Yes/No

B. CAPA SLA (define the cadence of containment → root cause → effectiveness)

Mini example (anonymized, editable):

• Day 0: Distributor submits complaint with photos + lot/expiry + quantity affected; supplier acknowledges receipt.

• Day 1–2 (containment): Supplier issues shipment hold for the lot, starts trace-back (finished goods lot → key material lots + process records), and confirms sample return/collection.

• Day 5–10 (initial update): Supplier shares an interim report: scope, suspected failure mode, and preliminary risk assessment.

• Day 15–30 (root cause): Supplier documents root cause using an agreed method (e.g., 5-Why / fishbone) and provides objective evidence (inspection records, in-process data, packaging/sterilization release records as applicable).

• Day 30–45 (CAPA plan): CAPA plan issued (correction + corrective action), with owners, due dates, and verification method.

• Day 60–90 (closure): CAPA closed with evidence; effectiveness check defined (e.g., next 3 lots or 90–180 days).

Document pack to request: complaint record, acknowledgement timestamp, traceability report, containment record, investigation report, CAPA plan/closure, and effectiveness-check evidence.

• Containment expectation is defined (quarantine, shipment hold, trace scope). Yes/No

• Root-cause method expectations are defined (and what “good enough” evidence looks like). Yes/No

• CAPA plan due date is defined: ________ Yes/No

• Effectiveness check expectation is defined (how closure is verified). Yes/No

C. Change notification (prevent “silent changes” that create downstream risk)

Common QMS anchors (examples): ISO 13485 4.1.4 (QMS changes), 7.4.1–7.4.3 (supplier control), 8.2.2 (complaints), and 8.5.2–8.5.3 (CAPA) are often used as reference points when drafting change-notification and quality-agreement clauses.

• Changes requiring prior notification are listed (materials, suppliers, equipment, site, packaging, labeling, test methods). Yes/No

• Notification lead time is defined: ________ Yes/No

• Approval rule is defined (inform vs approve-before-change). Yes/No

• Documentation for impact assessment is defined. Yes/No

Copy/paste templates (RFQ questions + clause starter lines)

RFQ question list (copy/paste)

1. Confirm the allowed MOQ structures: per SKU, per case, per shipment, and whether mixed-SKU orders can be combined to meet MOQ.

2. Define lead time start/end points and whether timelines are calendar or business days.

3. Define OTIF and whether split shipments can count as “in full.”

4. Provide the required per-lot documentation pack and delivery method.

5. Demonstrate traceability depth (finished goods lot → key materials/process records) and expected retrieval time.

6. Confirm shelf-life minimum at receipt and warehouse rotation expectations (FEFO).

7. Provide complaint handling workflow and agreed SLA targets (acknowledge, initial update, final response).

8. Provide CAPA workflow and agreed SLA targets (containment, plan due, closure, effectiveness check).

9. Provide change notification list and lead time.

10. Confirm post-award support contacts for supply and QA.

SLA clause starter lines (fill-in)

• Lead time: “Lead time shall mean ________ from ________ to ________ measured in ________ days, at PO-line level.”

  • Example (editable): “45 calendar days from PO acceptance (order acknowledgment issued) to ship date (ex-works).”

• OTIF: “OTIF shall mean ________ measured against ________ with the following split shipment rule: ________.”

  • Example (PO-line level): “OTIF = (# PO lines delivered on time AND in full ÷ total PO lines) × 100; split shipments count as NOT in full unless pre-approved in writing.”

• Shelf life at receipt: “Minimum remaining shelf life upon receipt shall be ________ unless otherwise agreed in writing.”

  • Example (editable): “Minimum remaining shelf life upon receipt shall be ≥ 75% of labeled shelf life (or ≥ 18 months, whichever is shorter).”

• Complaint SLA: “Supplier shall acknowledge complaints within ________ and provide an initial investigation update within ________.”

  • Example (editable): acknowledge within 2 business days; initial update within 10 business days; final response within 30 calendar days (or an agreed interim-update cadence).

• CAPA SLA: “Where CAPA is required, Supplier shall provide a CAPA plan within ________ and closure within ________, including effectiveness check documentation.”

  • Example (editable): CAPA plan within 15 business days; closure within 90 calendar days; effectiveness check at 90–180 days post-implementation.

• Change notification: “Supplier shall notify Buyer at least ________ prior to any change to ________ and shall not implement changes requiring approval without written authorization.”

  • Example (editable): notify ≥ 60 calendar days prior for material/process/site/labeling changes; “approval-before-change” applies to labeling, sterilization parameters, and critical material substitutions.

Key takeaways

• SLAs only work when the metrics are defined precisely and measured consistently.

• For medical dressings, commercial terms must be paired with traceability, shelf-life, and complaint/CAPA expectations.

• Your best risk reduction tool is a checklist that creates auditable yes/no answers—before you place the PO.

About this checklist (version, compliance notes)

• Version: v1.1

• First published: 2026-05-26

• Last updated: 2026-05-26

• Intended use: Procurement and QA alignment for medical dressing supply programs (decision-stage POs). This is a practical checklist, not legal advice.

• Market scope: Global programs. Regulatory references are provided as examples (e.g., U.S. FDA UDI: 21 CFR 801 Subpart B / Part 830; EU MDR UDI: Article 27 + Annex VI). Always confirm the exact obligations for your device classification and market.

• Prepared by: SLK Medical — Supply Chain & Quality Team

• Feedback / corrections: https://www.slkmedical.com/contact/

Next steps (SLK Medical)

If you want, SLK Medical can support your procurement and QA teams with a documentation-first onboarding package (spec sheet/IFU where applicable, traceability approach overview, and a draft supplier-quality-agreement checklist).

For distributor programs, reach out to the SLK Medical supply and QA teams to align on: mix-and-match PO rules, document pack requirements, and complaint/CAPA escalation paths.